Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand

Journal of Neurosurgery

Volumn 105, Issue 1, 2006, Pages 88-95

  Germano, Isabelle M ^a   Uzzaman, Mahmud ^a   Benveniste, Ronald J ^a   Zaurova, Milana ^a   Keller, Gordon ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocyte; Embryonic stem cell; Gene therapy; Malignant glioma; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

DEATH RECEPTOR 5; DOXYCYCLINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYONIC STEM CELL; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ASTROCYTES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DOXYCYCLINE; GENES, TRANSGENIC, SUICIDE; GLIOBLASTOMA; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; STEM CELLS; TISSUE ENGINEERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745563200     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2006.105.1.88     Document Type: Article

References (39)

1. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al: Neural stem cells display extensive tropism for pathology in the adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A 97:12846-12851, 2000
2. Almasan A, Ashkenazi A: Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14:337-348, 2003
3. Arizono Y, Yoshikawa H, Naganuma H, Hamada Y, Nakajima Y, Tasaka K: A mechanism of resistance to TRAIL/Apo2L induced apoptosis of newly established glioma cell line and sensitization to TRAIL by genotoxic agents. Br J Cancer 88: 298-306, 2003
4. Ashkenazi A, Dixit VM: Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11:255-260, 1999
5. Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, Rigamonti D, et al: Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 6:447-450, 2000
6. Benveniste RJ, Keller G, Germano IM, et al: Embryonic stem cell-derived astrocytes expressing drug-inducible transgenes: differentiation and transplantion into the mouse brain. J Neurosurg 103:115-123, 2005
7. Chen Y, Swanson RA: Astrocytes and brain injury. J Cereb Blood Flow Metab 23:137-149, 2003
8. Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, et al: Combined effect of tumor necrosis factorrelated apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci U S A 97:1754-1759, 2000
9. Chiocca EA: Gene therapy: a primer for neurosurgeons. Neurosurgery 53:364-373, 2003
10. Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, et al: Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 62:7170-7174, 2002
11. Eriksson C, Ericson C, Gates MA, Wictorin K: Long-term, EGFstimulated cultures of attached GFAP-positive cells derived from the embryonic mouse lateral ganglionic eminence: in vitro and transplantation studies. Exp Neurol 164:184-199, 2000
12. Frank S, Kohler U, Schackert G, Schackert HK: Expression of TRAIL and its receptors in human brain tumors. Biochem Biophys Res Commun 257:454-459, 1999
13. Fulda S, Wick W, Weller M, Debatin KM: Smac agonists sensitize for Apo2L/TRAIL-or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8: 808-815, 2002
14. Germano IM, Fable J, Gultekin SH, Silvers A: Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas. J Neurooncol 65:279-289, 2003
15. Grataroli R, Vindrieux D, Selva J, Felsenheld C, Ruffion A, Decaussin M, et al: Characterization of tumor necrosis factor-α-related apoptosis-inducing ligand and its receptors in the adult human testis. Mol Hum Reprod 10:123-128, 2004
16. Gupta T, Sarin R: Poor-prognosis high-grade gliomas: evolving an evidence-based standard of care. Lancet Oncol 3:557-564, 2002
17. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, MacCormack MP, Wulffraat N, et al: LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-419, 2003
18. Hao C, Berguinot F, Condorelli G, Trencia A, Van Meier EG, Yong VW, et al: Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res 61:1162-1170, 2001
19. Hilliard B, Wilmen A, Seidel C, Liu TS, Göke R, Chen Y: Role of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J Immunol 166:1314-1319, 2001
20. Kagawa S, He C, Gu J, Koch P, Rah SJ, Roth JA, et al: Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 61:3330-3338, 2001
21. Kelley SK, Harris LA, Xie D, Deforge L, Totpal K, Bussiere J, et al: Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety. J Pharmacol Exp Ther 299:31-38, 2001
22. Kyba M, Perlingeiro RCR, Daley GQ: HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109:29-37, 2002
23. Lee J, Hampl M, Albert P, Fina HA: Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector. Neoplasia 4:312-323, 2002
24. MacFarlane M: TRAIL-induced signalling and apoptosis. Toxicol Lett 139:89-97, 2003
25. Mariani SM, Matiba B, Armandola EA, Krammer PH: Interleukin 1β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J Cell Biol 137:221-229, 1997
26. Nagane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK, Huang HJ: Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res 60:847-853, 2000
27. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A: Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687-12690, 1996
28. Ridet JL, Sarkis C, Serguera C, Zennou V, Charneau P, Mullet J: Transplantation of human adult astrocytes: efficiency and safety requirements for an autologous gene therapy. J Neurosci Res 72:704-708, 2003
29. Rieger J, Naumann U, Glaser T, Ashkenazi A, Weller M: Apo2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett 427:124-128, 1998
30. Ryan LA, Peng H, Erichsen DA, Huang Y, Peridsky Y, Zhou Y, et al: TNF-related apoptosis inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia. J Neuroimmunol 148:127-139, 2004
31. Sauer B, Henderson N: Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A 85:5166-5170, 1988
32. Selkirk SM, Greenberg SJ, Plunkett RJ, Barone TA, Lis A, Spence PO: Syngeneic central nervous system transplantation of genetically transduced mature, adult astrocytes. Gene Ther 9: 432-443, 2002
33. Shah K, Tang Y, Breakefield X, Weissleder R: Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo. Oncogene 22:6865-6872, 2003
34. Shankar S, Srivastava RK: Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. Drug Resist Updat 7:139-156, 2004
35. Song JH, Song DK, Pyrzynska B, Petruk KC, Van Meier EG, Hao C: TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways. Brain Pathol 13:539-553, 2003
36. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Methods 184:39-51, 1995
37. Wang S, El-Deiry WS: TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22:8628-8633, 2003
38. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, et al: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157-163, 1999
39. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682, 1995